50% off Premium Yearly

NASDAQ:MDLZ
This summary was created by AI, based on 2 opinions in the last 12 months.
MDLZ-Q, the stock of Mondelez International Inc., has been facing significant challenges recently. Experts point to two main reasons for the weakness: the end of pandemic-era pantry-stuffing and soaring cocoa prices driven by plant diseases in West Africa. Since chocolate has no easy substitutes, the company's ability to manage costs and pricing remains limited, creating uncertainty for investors. If purchasing at this point, one should anticipate potential drops in capital, especially considering the growing consumer shift towards healthier options and the impact of GLP-1 drugs. Furthermore, foreign exchange rates add another layer of complexity in translating these challenges back to USD, making it a cautious investment opportunity for those with a long-term horizon.
Came out of Kraft, as the snack piece. Growing well organically, 6.3% y/y. Prides itself on stability. Snacks are evolving; there are healthy options. Worldwide opportunity for expansion, sub-20x earnings, good dividend. The side of the barbell that gives stability to counteract the octane of tech. Yield is 2.21%. (Analysts’ price target is $62.96)
(A Top Pick Aug 13/19, Up 4%) Still likes it. They make snacks globally with only 26% of revenues from North America. They benefitted from the pandemic, because consumers stuck to well-known brands like theirs. Emerging markets will grow faster, though enjoyed good growth in developed ones. She likes the global snacking space because it's high growth. They boast a valuation discount vs. Coke and Pepsi.
These companies are benefiting from the stay-at-home trend. There has been talk of merging with Kraft and that has kept the stock up. There is a lot of growth in the international side.
(A Top Pick May 13/20, Up 29%) Has owned this for years and will hang on. They posted a good quarter recently. When the pandemic hit, consumers stuck to big brands like Ritz Crackers, but MDLZ also attracted new customers. So, MDLZ advertised to keep and attract customers which paid off with organic growth. The valuation gap between MDLZ and global staples like Pepsi will close over time. Too pricey now, so buy on dips. 40% of business is in emerging markets and will grow further there.